Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo

Published:2018-05-03 Issue:15 Volume:24 Page:3729-3740
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Laszlo Viktoria,Valko Zsuzsanna,Kovacs Ildiko,Ozsvar Judit,Hoda Mir Alireza,Klikovits Thomas,Lakatos Dora^ORCID,Czirok Andras^ORCID,Garay Tamas,Stiglbauer Alexander,Helbich Thomas H.,Gröger Marion,Tovari Jozsef,Klepetko Walter,Pirker Christine,Grusch Michael,Berger Walter,Hilberg Frank,Hegedus Balazs,Dome Balazs

Funder

Boehringer Ingelheim RCV GmbH

Vienna Fund for Innovative Interdisciplinary cancer Research

Hungarian Academy of Sciences

Herzfelder'sche Familienstiftung (Herzfelder Family Foundation)

Initiative for Cancer Research of the Medical University of Vienna

Austrian National Bank

Hungarian National Research, Development and Innovation Office

Semmelweis University Start-Up grant

Ausztrian Science Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathogenesis mechanism and potential clinical value of lncRNA in gliomas;Discover Oncology;2024-07-05

2. Development and characterization of inhaled nintedanib-loaded PLGA nanoparticles using scalable high-pressure homogenization technique;Journal of Drug Delivery Science and Technology;2024-01

3. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis;Biomedicine & Pharmacotherapy;2023-07

4. Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation;Lung Cancer;2023-06

5. Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?;International Journal of Molecular Sciences;2023-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3